×
About 6,120 results

ALLMedicine™ Cerebrovascular Events Center

Research & Reviews  1,915 results

Randomized Trial of Surgical Left Atrial Appendage Closure: Protection Against Cerebrov...
https://doi.org/10.1053/j.semtcvs.2022.06.012
Seminars in Thoracic and Cardiovascular Surgery; Madsen CV, Park-Hansen J et. al.

Jul 2nd, 2022 - Following open-heart surgery, atrial fibrillation and stroke occur frequently. Left atrial appendage closure added to elective open-heart surgery could reduce the risk of ischemic stroke. We aim to examine if routine closure of the left atrial app...

The MRI enhancement ratio and plaque steepness may be more accurate for predicting recu...
https://doi.org/10.1007/s00330-022-08893-2 10.1161/strokeaha.113.003508 10.1161/strokeaha.119.028405 10.1212/01.wnl.0000175983.76110.59 10.1212/01.wnl.0000208404.94585.b2 10.1016/j.jbiomech.2014.01.013 10.1038/nrcardio.2009.246 10.1016/j.jcmg.2012.03.014 10.1007/s00330-015-4008-5 10.1177/1747493015609775 10.1007/s00234-020-02418-8 10.1136/svn-2018-000228 10.1159/000093241 10.1038/s41598-021-88593-x 10.1016/j.jacc.2020.12.015 10.1161/strokeaha.115.011086 10.3389/fneur.2020.00755 10.1002/jmri.27351 10.1159/000462994 10.1161/strokeaha.113.003140 10.1161/strokeaha.112.662692 10.1161/circulationaha.104.528174 10.1186/s12968-021-00766-9 10.3174/ajnr.A2863 10.1115/1.4003439 10.1016/j.ejvs.2010.07.015 10.1136/jnnp-2020-325027 10.1002/ana.25456 10.1161/circulationaha.111.021824 10.1016/s1474-4422(18)30233-3 10.1136/jnnp-2019-322424 10.1038/nrneurol.2014.72 10.1002/jmri.27516 10.1007/s00330-020-07055-6 10.1161/circulationaha.105.578229 10.1056/NEJMoa1105335 10.1016/j.jocn.2014.10.018 10.1161/01.cir.78.5.1157 10.1016/j.jacc.2021.01.038 10.1016/j.jcmg.2019.03.028 10.1002/ana.22626 10.1016/j.atherosclerosis.2014.10.007 10.1016/j.atherosclerosis.2016.03.033 10.1186/1532-429x-13-64
European Radiology; Yang D, Liu J et. al.

Jul 1st, 2022 - To assess the complementary value of high-resolution multi-contrast MRI (hrMRI) in identifying symptomatic patients with intracranial atherosclerosis (ICAS) who are likely to experience recurrent ischemic cerebrovascular events. In this retrospect...

Colchicine in High-risk Patients With Acute Non-disabling Cerebrovascular Events (CHANCE-3)
https://clinicaltrials.gov/ct2/show/NCT05439356

Jun 30th, 2022 - This is a multicentre, randomized, double-blind, placebo-controlled trial that aims to investigate the efficacy of colchicine in preventing recurrent stroke in the patients with high-risk non-disabling cerebrovascular events and a hsCRP level of ≥...

Plasma C4 level was associated with mortality, cardiovascular and cerebrovascular compl...
https://doi.org/10.1186/s12882-022-02829-0 10.1016/j.kint.2018.11.046 10.1186/1471-2369-14-50 10.1146/annurev.med.55.091902.103801 10.1053/j.ajkd.2019.09.003 10.1056/NEJMoa041031 10.1111/sdi.12694 10.1016/j.ijcard.2017.02.095 10.1038/nrneph.2017.17 10.1056/NEJM197704072961401 10.1038/ki.1983.225 10.1016/j.molimm.2014.06.038 10.1159/000451060 10.1111/j.1523-1755.1998.00836.x 10.1007/s12265-019-09885-2 10.1186/s12967-016-0995-5 10.1111/cei.12777 10.1159/000442426 10.1016/j.clim.2009.04.005 10.1016/j.humimm.2010.06.001 10.1097/01.hjr.0000244582.30421.b2 10.1161/01.ATV.0000240517.69201.77 10.1084/jem.20041431 10.1007/s11255-011-0085-9 10.1016/0021-9681(87)90171-8 10.1056/NEJM197112232852601 10.1161/STROKEAHA.108.192218 10.1159/000451052 10.1186/s12882-021-02579-5 10.1158/1078-0432.CCR-04-0713 10.1186/1471-2369-15-162 10.1016/S0145-305X(01)00034-9 10.1111/eci.12275 10.1097/MOL.0b013e3282f4096b 10.1007/978-1-61779-842-9_9 10.1007/s12020-018-1712-3 10.1038/srep18713 10.1055/s-0039-1692426 10.2174/1573399814666180417122030 10.1161/01.CIR.0000140677.20606.0E 10.3892/mmr.2017.6736 10.1074/jbc.M116.731141 10.1159/000452269 10.1073/pnas.1707364114 10.1111/j.1538-7836.2006.02065.x 10.1016/j.smim.2018.01.003 10.1053/j.jrn.2008.08.003 10.1016/j.kint.2017.01.038 10.1016/0272-6386(95)90177-9 10.1053/ajkd.2001.20756 10.1253/circj.CJ-14-0915 10.1056/NEJM199309303291404 10.3945/ajcn.111.014639 10.1038/ki.2012.130 10.1186/1471-2369-14-72 10.1074/jbc.M105934200
BMC Nephrology; Xing Z, Wang Y et. al.

Jun 30th, 2022 - Patients on maintenance hemodialysis (HD) exhibit a high risk of death, cardiovascular and cerebrovascular diseases (CCDs). Previous studies indicated complement activation associated with the increased risk of cardiovascular diseases in HD patien...

see more →

Guidelines  3 results

Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With...
https://doi.org/10.1001/jama.2018.8357
JAMA , Curry SJ et. al.

Jul 13th, 2018 - Peripheral artery disease (PAD) is a manifestation of atherosclerosis in the lower limbs. It can impair walking and, in severe cases, can lead to tissue loss, infection, and amputation. In addition to morbidity directly caused by PAD, patients wit...

ESVS Guidelines: Section B - diagnosis and investigation of patients with carotid steno...
https://doi.org/10.2174/157016110792006888
Current Vascular Pharmacology; Liapis CD, Bell PF et. al.

Jun 25th, 2010 - Herein, we present the European Society for Vascular Surgery Guidelines pertinent to the secondary prevention of cerebrovascular events in patients with carotid artery stenosis including lipid lowering therapy, antiplatelet therapy and other risk ...

ESVS Guidelines: Section A--prevention in patients with carotid stenosis.
https://doi.org/10.2174/157016110792006905
Current Vascular Pharmacology; Liapis CD, Bell PF et. al.

Jun 25th, 2010 - Herein, we present the European Society for Vascular Surgery Guidelines pertinent to the secondary prevention of cerebrovascular events in patients with carotid artery stenosis including lipid lowering therapy, antiplatelet therapy and other risk ...

see more →

Drugs  25 results see all →

Clinicaltrials.gov  197 results

Colchicine in High-risk Patients With Acute Non-disabling Cerebrovascular Events (CHANCE-3)
https://clinicaltrials.gov/ct2/show/NCT05439356

Jun 30th, 2022 - This is a multicentre, randomized, double-blind, placebo-controlled trial that aims to investigate the efficacy of colchicine in preventing recurrent stroke in the patients with high-risk non-disabling cerebrovascular events and a hsCRP level of ≥...

Early Vascular Ageing in the YOUth
https://clinicaltrials.gov/ct2/show/NCT04598685

Jun 24th, 2022 - EVA4YOU is a cross-sectional study enrolling 3000 students and apprentices aged between 14 and 19 years. Examinations are conducted at schools and companies throughout Tyrol, Austria and include laboratory measurements; standardized medical interv...

C-arm Cone Beam CT Perfusion Guided Cerebrovascular Interventions
https://clinicaltrials.gov/ct2/show/NCT03232151

May 31st, 2022 - This is an evaluation to determine the efficacy of the use of C-arm CBCT with SMART RECON novel software for the rapid assessment of time-resolved CTA and CT perfusion in the setting of ischemic cerebrovascular events. As a leading center for the ...

Effect of Empagliflozin on Liver Fat in Non-diabetic Patients
https://clinicaltrials.gov/ct2/show/NCT04642261

May 25th, 2022 - Non-alcoholic fatty liver disease (NAFLD) is a global epidemic with a prevalence of 25%. Currently therapies for NAFLD patients without diabetes mellitus (DM) are limited, and are associated with various adverse side effects. Sodium-glucose cotran...

Valvosoft First-In-Human Study in Severe Symptomatic Aortic Stenosis
https://clinicaltrials.gov/ct2/show/NCT04665596

May 25th, 2022 - CARDIAWAVE has developed a new non-invasive, real-time image-guided, therapeutic approach to treat patients suffering from Calcified Aortic Stenosis. CARDIAWAVE's Valvosoft device is a new ultrasound therapy based on a disruptive technology involv...

see more →

News  308 results

Switch to Prasugrel Safe After PCI in East Asian ACS Patients
https://www.medscape.com/viewarticle/976418

Jun 30th, 2022 - The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer-reviewed. Key Takeaways Korean acute coronary syndrome (ACS) patients who were started and remained on prasugrel after percutaneous coron...

Women Benefit but Lag Behind in Intracoronary Imaging in PCI
https://www.medscape.com/viewarticle/975921

Jun 20th, 2022 - A real-world analysis reveals that women are consistently less likely to undergo intracoronary imaging as part of percutaneous coronary intervention (PCI), even though it benefits both sexes equally. Results from nearly all PCIs performed in Engla...

Hormone Therapy May Still Have Role in Osteoporosis Treatment
https://www.medscape.com/viewarticle/970590

Mar 18th, 2022 - Doctors' opinions about whether to treat women with osteoporosis with hormone therapy vary. Guidelines by medical societies including those of the American College of Physicians, on the other hand, generally do not recommend it as a first line the...

Hormone therapy may still have role in osteoporosis treatment
https://www.mdedge.com/internalmedicine/article/252874/womens-health/hormone-therapy-may-still-have-role-osteoporosis
Roxanne Nelson

Mar 17th, 2022 - Doctors’ opinions about whether to treat women with osteoporosis with hormone therapy vary. Guidelines by medical societies including those of the American College of Physicians, on the other hand, generally do not recommend it as a first line the.

Discharge Beta Blockers, RAS Inhibitors Cut Late Risk in MI With Mid-Range EF
https://www.medscape.com/viewarticle/970381

Mar 16th, 2022 - The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Beta-blocker therapy at discharge in patients with mildly reduced left ventricular ejection fraction (LVEF, 40% - 49%) a...

see more →